Prime Medicine, Inc.

Q4 2023 13F Holders

Symbol
PRME
CUSIP
74168J101
Type
Equity
Class
COM
Num filings
113
Total reported value, excl. options
$434 M
Manager Report Date Value ($000) Shares Option Type